Tag: Restricted emergency use
DCGI nods for restricted emergency use of Itolizumab for Covid-19 patients
Itolizumab (rDNA origin), a monoclonal antibody that was already approved for severe chronic plaque psoriasis, has now been granted Restricted Emergency Use authorization by...
